Publication Type
Press & Digital Campaign
At Indena, we continuously expand to stay ahead of clients’ emerging needs and to provide innovative, tailored solutions for the pharmaceutical industry.
With 100+ years of experience in complex APIs, leading technologies, R&D and industrialization, we now manufacture 10 commercial and 12 clinical-phase HPAPIs: fully synthetic, semi-synthetic, and fermentation molecules, including ADC payloads, with OEL as low as 1ng/m3.
Alongside our state-of-the-art labs, investing in high-capacity industrial GMP assets – including 10,000-l reactors and a 250-l hydrogenator – allows us to also develop, produce, and market high volumes with unmatched agility.
Partner with us for advanced CDMO solutions that adhere to the strictest standards for quality, safety, and sustainability.
Sorry, our website doesn't support IE11 and older versions
For a better experience try a modern browser:
This is a private file, to request the download of this resource, please fullfill the fields below.